Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
222.9 USD | -1.09% | +1.91% | -13.78% |
05-09 | MOVES -Lazard hires veteran healthcare dealmaker Colocci as vice chairman | RE |
05-08 | Redburn Atlantic Adjusts Price Target on Biogen to $235 From $275, Keeps Neutral Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.78% | 32.81B | |
-2.47% | 89.37B | |
+2.76% | 40.65B | |
+51.84% | 25B | |
-16.77% | 15.29B | |
-42.60% | 11.61B | |
-10.48% | 11.49B | |
+5.84% | 8.98B | |
-7.72% | 8.23B | |
-7.85% | 7B |
- Stock Market
- Equities
- BIIB Stock
- News Biogen Inc.
- Piper Sandler Adjusts Biogen Price Target to $325 From $350, Maintains Overweight Rating